Pregled bibliografske jedinice broj: 121231
BPC 157 related inhinhibition of cell growth in human melanoma cell line BPC 157- related inhibition of cell growth in human melanoma cell line
BPC 157 related inhinhibition of cell growth in human melanoma cell line BPC 157- related inhibition of cell growth in human melanoma cell line // Abstracts of the 19th European Congress of Pathology
Ljubljana, Slovenija, 2003. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 121231 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
BPC 157 related inhinhibition of cell growth in human melanoma cell line BPC 157- related inhibition of cell growth in human melanoma cell line
Autori
Radeljak, Sanja ; Batelja, Lovorka ; Mirt, Mirela ; Alemka, B. ; Sikirić, Predrag ; Seiwerth, Sven
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the 19th European Congress of Pathology
/ - , 2003
Skup
European Congress of Pathology (19 ; 2003)
Mjesto i datum
Ljubljana, Slovenija, 06.09.2003. - 11.09.2003
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
melanoma cell line; inhibition of cell growth; BPC 157
Sažetak
Melanoma therapy still remains without notable success of any pharmacological agent. Gastric pentadecapeptide BPC 157 is a peptide with various pharmacological effects on different organ systems including wound healing and inflammation. Its possible effect on cell growth and differentiation was not investigated on human cancer cell lines. Materials and Methods: Human melanoma cells were maintained in RPMI-1840 medium supplemented with 10% FBS and antibiotics. Cells were grown to confluency in humidified incubator (95% air atmosphere, 5%.CO2) at 37°C. Upon reaching confluency, cells were maintained in chemically defined medium (CDM). BPC157 was added in the culture medium in the various concentrations (2 pg. and 2ng, respectively) for a period of 48 hours. Cell morphology was observed daily under light microscope and the photomicrographs were taken. After harvesting cells were prepared in EtOH for flow cytometry analysis. Results: Microscopy did not reveal any changes upon treatment with BPC 157 after 48h comparing to controls. Flow cytometry showed 99% of cells (p<0.01) were in G0-G1 phase. Control cells had total S-phase fraction of 9.11%. However, upon introduction of BPC 157, in concentration of 2pg/ml, the percentage of cells in S-phase was decreased by 20% compared to controls. Moreover, the concentration of 2 ng/ml BPC 157 lowered total S-phase fraction by 55% comparing to controls and by 30% comparing to BPC 157 in picogram values (p<0.01). Conclusion: We assume that gastric pentadecapeptide BPC 157 could act as a inhibitory agent during G1-S transition state of cell cycle thereby preventing DNA synthesis and cell growth.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb